Clinical Trials · NCT02650479
Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Intarcia Therapeutics
- Enrollment
- 82
- Start date
- Jan 2016
- Locations
- 1 site, Netherlands
- Primary endpoint
- Pilot Study: Establishment of mean plasma steady state concentration of 500 pg/mL